Cases were not evenly distributed across the North East. The study team observed a marked concentration of suspected opioid-associated out-of-hospital cardiac arrest events in the most deprived communities: 71.8% of incidents were in Index of Multiple Deprivation (IMD) deciles 1–3. This clustering suggests a geographically localised burden of suspected drug-related cardiac arrests that aligns with existing mortality trends for drug poisoning in the region. The authors reported that these spatial patterns may inform resource allocation and targeted community interventions; the source did not, however, provide detailed mapping images or specific postcode-level counts in the manuscript.
The cohort comprised 351 included incidents recorded between 1 January 2022 and 31 December 2024. The mean age was 42.9 years and 69.2% were male. Over the three-year window the proportion of resuscitation-attempted out-of-hospital cardiac arrests represented by suspected OA-OHCA increased from 4.7% in 2022 to 5.9% in 2024, indicating a rising relative caseload for NEAS. The study team did not report additional demographic breakdowns such as ethnicity or comorbidity prevalence in the manuscript. The data source was the NEAS electronic patient care record (ePCR) and inclusion required documented cardiac resuscitation plus either a reported drug overdose aetiology or recorded naloxone administration.
Treatment patterns were consistent across the cohort and focused on airway, ventilation, and vascular access. Advanced airway management was recorded in 88.3% of cases; intraosseous access was used in 75.5%. Pharmacologic interventions included naloxone administration in 87.2% of incidents and adrenaline in 86.9%; amiodarone was documented in 9.4% of cases. Defibrillation occurred infrequently, recorded in 16.5% of incidents. The authors did not report finer-grained timing metrics for drug or airway interventions, such as time-to-naloxone or sequence of airway versus vascular access attempts. Those operational details were not available in the structured fields used for this evaluation.
Data indicated a treatment pattern consistent with an asphyxial arrest model: frequent airway and ventilation management alongside high rates of vascular access and naloxone delivery, with defibrillation uncommon. The study team interpreted the low defibrillation frequency as consistent with non-shockable rhythms being more prevalent in suspected opioid-related arrests. The source did not provide cardiac rhythm distributions or ECG waveform data in the manuscript to directly quantify shockable versus non-shockable presentation, so this physiological inference is based on the pattern of interventions recorded rather than direct rhythm reporting.
Investigators performed a retrospective service evaluation using structured and reported fields from the NEAS ePCR covering 2022–2024. Inclusion required both documented cardiac resuscitation and either a recorded overdose aetiology or documented naloxone administration; these criteria were applied to routinely collected ambulance records. NEAS acted as data controller and granted access for the evaluation; the underlying patient-level dataset is held by NEAS and cannot be shared publicly. The manuscript states that anonymised data may be made available on reasonable request subject to NEAS information governance and a data sharing agreement. Ethical approval was obtained through Northumbria University (Project No. 8566; approval date 19/05/2025). Funding came via an NIHR pre-doctoral fellowship; the funder had no role in design, analysis, or reporting.
This evaluation is descriptive and relies on routinely recorded ePCR fields, which limits the granularity of available clinical detail. The authors noted, for example, that the manuscript did not include rhythm strip data, time-stamped intervention sequencing, or comprehensive demographic variables such as ethnicity and comorbidity. The preprint status on medRxiv means the work has not undergone peer review and should not be used to alter clinical practice. The study provides a baseline for NEAS service planning and, according to the authors, forms the empirical foundation for a subsequent qualitative study exploring paramedic clinical decision-making in suspected OA-OHCA. Remaining questions documented in the source include how paramedics balance airway and pharmacologic interventions during OA-OHCA, optimal timing and dosing of naloxone in cardiac arrest contexts, and whether targeted community interventions could reduce incidence in high-IMD areas. The manuscript did not report outcome measures such as survival to hospital discharge or neurologic outcome, nor did it report detailed timing metrics for interventions; those gaps define priorities for future data collection and analysis.